Recently personalized medicine and dynamic treatment regimes have drawn considerable attention. Dynamic treatment regimes are rules that govern the treatment of subjects depending on their intermediate responses or covariates. Two-stage randomization is a useful set-up to gather data for making inference on such regimes. Meanwhile, the number of clinical trials involving competing risk censoring has risen, where subjects in a study are exposed to more than one possible failure and the specific event of interest may not be observed because of competing events. We aim to compare several treatment regimes from a two-stage randomized trial on survival outcomes that are subject to competing risk censoring. The cumulative incidence function (CIF)...
We suggest a new simple approach for estimation and assessment of covariate effects for the cumulati...
Competing risks data arise frequently in clinical trials. When the proportional subdistribution haza...
Sequentially randomized designs are becoming common in biomedical research, particularlyin clinical ...
Recently personalized medicine and dynamic treatment regimes have drawn considerable attention. Dyna...
In recent years, personalized medicine and dynamic treatment regimes have drawn considerable attenti...
Recently dynamic treatment regimens (DTRs) have drawn considerable attention, as an effective tool f...
Although cumulative incidence function (CIF) estimates are commonly used to describe the failure pro...
BackgroundIn many studies, some information might not be available for the whole cohort, some covari...
Statistical techniques such as Kaplan-Meier estimate is commonly used and interpreted as the probabi...
Abstract Background In many studies, some information might not be available for the whole cohort, s...
Estimating cumulative event probabilities in time-to-event data can be complicated by competing even...
This thesis contains two parts focusing on regression analysis and diagnostic accuracy analysis of c...
Clinical trials and cohort studies that collect survival data frequently involve patients who may fa...
Adaptive treatment regime is a set of rules that governs the assignment of time-varying treatment ba...
Competing risks occur in survival analysis when an individual is at risk of more than one type of ev...
We suggest a new simple approach for estimation and assessment of covariate effects for the cumulati...
Competing risks data arise frequently in clinical trials. When the proportional subdistribution haza...
Sequentially randomized designs are becoming common in biomedical research, particularlyin clinical ...
Recently personalized medicine and dynamic treatment regimes have drawn considerable attention. Dyna...
In recent years, personalized medicine and dynamic treatment regimes have drawn considerable attenti...
Recently dynamic treatment regimens (DTRs) have drawn considerable attention, as an effective tool f...
Although cumulative incidence function (CIF) estimates are commonly used to describe the failure pro...
BackgroundIn many studies, some information might not be available for the whole cohort, some covari...
Statistical techniques such as Kaplan-Meier estimate is commonly used and interpreted as the probabi...
Abstract Background In many studies, some information might not be available for the whole cohort, s...
Estimating cumulative event probabilities in time-to-event data can be complicated by competing even...
This thesis contains two parts focusing on regression analysis and diagnostic accuracy analysis of c...
Clinical trials and cohort studies that collect survival data frequently involve patients who may fa...
Adaptive treatment regime is a set of rules that governs the assignment of time-varying treatment ba...
Competing risks occur in survival analysis when an individual is at risk of more than one type of ev...
We suggest a new simple approach for estimation and assessment of covariate effects for the cumulati...
Competing risks data arise frequently in clinical trials. When the proportional subdistribution haza...
Sequentially randomized designs are becoming common in biomedical research, particularlyin clinical ...